Sou Hu Cai Jing·2025-07-30 13:57Group 1 - The core viewpoint of the news indicates that ST Unimed (002581) has experienced a decline in stock price and significant net outflow of funds, reflecting investor sentiment and market activity [1][3] - As of July 30, 2025, ST Unimed's stock closed at 7.21 yuan, down 2.44%, with a turnover rate of 3.19% and a trading volume of 128,000 hands, amounting to a transaction value of approximately 93.30 million yuan [1] - The latest financial performance report for ST Unimed shows total operating revenue of 35.33 million yuan, a year-on-year decrease of 57.84%, and a net profit attributable to shareholders of 36.85 million yuan, down 33.01% year-on-year [1] Group 2 - The company has made significant investments, with a total of 11 external investments and participation in 7 bidding projects, indicating active engagement in business expansion [2] - ST Unimed holds 4 administrative licenses, which may enhance its operational capabilities and regulatory compliance [2] - The company, established in 2000 and located in Zibo City, primarily operates in the pharmaceutical manufacturing industry, with a registered capital of approximately 6.60 billion yuan [1][2]